BETY program after knee injections for osteoarthritis
Part of Brain & nervous system, Pain clinical trials.
This trial tests if a special exercise and education program called BETY helps people with knee osteoarthritis feel better after getting a knee injection. You may qualify if you had a knee injection in the last month and have moderate knee arthritis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have knee osteoarthritis diagnosed by a doctor
- Your knee arthritis is moderate (stage 2 or 3 on an X-ray scale)
- You received a knee injection in the past month
- You are 18 years or older
- You can read and write
- You have not had knee surgery or a serious knee injury in the last 6 months
- You have not done physical therapy for your knee in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injection for knee osteoarthritis that aims to improve pain and function. It may help if you have moderate to severe knee pain that hasn't been relieved by first-line treatments.
This study tests a single injection into the knee joint to see if it relieves pain from knee osteoarthritis. It may help people who have tried other treatments without feeling better.
This study tests an experimental injection called GNSC-001 given directly into the knee to see if it can reduce pain and improve knee function in people with knee osteoarthritis. If you join, you'll have one injection and then be followed for a year, and you'll need to stop your usual knee pain medicines during the study.
This study compares a movement therapy called Basic Body Awareness Therapy to usual care for people with knee osteoarthritis. It aims to see if this therapy can improve pain, movement, and quality of life.
This trial tests if learning about chronic pain can help people with knee osteoarthritis feel better. You'll join a program that teaches you about pain and how to manage it.
This study tests a new cell-based injection (Allocetra) directly into the knee joint for people with moderate osteoarthritis who haven't benefited from other treatments. The goal is to reduce pain and improve knee function.
Hear when a new Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.